Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/30/2025

Mirtazapine Use in Pediatric Patients

Efficacy and Safety in Specific Contexts

  • The American Academy of Pediatrics suggests that mirtazapine may improve sleep disorders and behavioral symptoms in children with autism spectrum disorder, with doses of 7.5-45 mg daily showing efficacy in small studies 1, 2
  • The FDA has approved duloxetine, a serotonin-norepinephrine reuptake inhibitor, for pediatric anxiety disorders, indicating its potential as a preferred treatment option over mirtazapine 3